Skip to main content
Premium Trial:

Request an Annual Quote

Joseph Donahue, Thure Etzold, Peter Willinger

Premium

Joseph Donahue, most recently head of global sales and president of Lion Bioscience’s US subsidiary, has left the company, BioInform has learned. A company spokeswoman said that a replacement has not yet been named. Donahue joined Lion in 2003 as president of its North American operations. In October 2004, he was appointed co-CEO of the company, along with Thure Etzold. In November, Lion’s supervisory board removed Donahue from the executive board and appointed Etzold CEO and Peter Willinger CFO.

Filed under

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.